Ben Porter
Vice President

Ben has several years of experience analyzing both development stage and commercial stage biotechnology companies. 

Prior to joining K2HV, Ben was a Senior Associate on the Small-Mid Cap and Large Cap Biotechnology Equity Research teams at Stifel. He was responsible for conducting in-depth clinical and commercial diligence on numerous companies, with a particular focus in the autoimmune, metabolic, and oncology therapeutic areas. Additionally, Ben has experience with sophisticated financial analysis, as he began his equity research career in the Electrical Equipment / Multi-Industry sector before transitioning his focus to biotechnology.

Ben holds a B.A. in Economics from Bates College.